MRSA鼻腔筛查在抗菌药物管理中的临床效用:当前文献综述
本综述探讨MRSA鼻腔筛查预测MRSA感染的性能,及其在抗菌药物管理中的临床应用。在MRSA低流行率时,筛查阴性预测值高,可指导经验性抗菌药物选择,减少万古霉素使用。综述还讨论了实践考虑,并建议抗菌药物管理项目制定院内指南,药师可参与教育、解读和应用筛查结果。
要点
- MRSA鼻腔筛查阴性预测值高,可用于排除MRSA感染。
- 阴性筛查可避免或终止抗MRSA治疗,减少万古霉素疗程。
- 药师应参与筛查结果的解读、教育及临床应用。
核心结论
- MRSA鼻腔筛查阴性预测值高,是抗菌药物管理的有效工具,应用不限于下呼吸道感染。
研究设计与样本
- 本文为文献综述,回顾当前关于MRSA鼻腔筛查在抗菌药物管理中临床效用的研究。
主要发现
- 使用MRSA鼻腔筛查排除下呼吸道感染中的MRSA可显著缩短万古霉素治疗疗程。
- MRSA鼻腔筛查在其他类型感染中的临床效用尚不明确。
关键数值与推荐
- MRSA流行率低时,MRSA鼻腔筛查阴性预测值高。
- 对适当选择的患者,阴性筛查可预防启动或指导终止抗MRSA治疗。
临床怎么用
- 抗菌药物管理项目应制定院内指南,促进MRSA鼻腔筛查的正确使用。
- 药师可协助教育、解读和应用MRSA鼻腔筛查结果。
- 在适当选择的患者中,利用阴性筛查结果避免不必要的抗MRSA治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Significant clinical and financial consequences are associated with both inadequate and unnecessary exposure to broad-spectrum antibiotics. As such, antimicrobial stewardship programs seek objective, reliable, and cost-effective tests to identify patients at highest or lowest risk for drug-resistant organisms to guide empirical antimicrobial selection. Use of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA in lower respiratory tract infections has led to significant reductions in duration of vancomycin therapy. The clinical utility of MRSA nasal screening in other types of infection remains less clear. This review describes the performance of MRSA nasal screening in predicting MRSA infection, highlights practical considerations for use of MRSA nasal screening, and provides guidance for incorporating MRSA nasal screening into clinical practice. With a high negative predictive value when the prevalence of MRSA is low, MRSA nasal screening is a valuable antimicrobial stewardship tool with potential applications beyond lower respiratory tract infections. In appropriately selected patients, negative MRSA nasal screening can prevent initiation or guide discontinuation of anti-MRSA therapy. Antimicrobial stewardship programs should develop institutional guidelines to promote proper use of MRSA nasal screening. Pharmacists are well positioned to assist with education, interpretation, and application of MRSA nasal screening results.
引用
- Carr AL, Daley MJ, Givens Merkel K, et al. Clinical Utility of Methicillin-Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature. Pharmacotherapy. 2018. PMID: 30300441. doi:10.1002/phar.2188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。